Tacrolimus is an immunosuppressive drug that is given orally or intravenously to patients who have had a kidney, liver, heart, or other organ transplant.
Normally, a person’s immune system would recognise the new organ as foreign and begin to attack it. Tacrolimus limits this response and helps to prevent organ rejection by inhibiting the activation of T-lymphocytes.
Randox Toxicology have developed a new tacrolimus single-plex biochip assay which is available on the Evidence MultiSTAT, to aid in the monitoring of tacrolimus at the location of treatment.
Benefits
Product Information
Analyser Process
